TARGETING THE KEY

MECHANISMS

RESPONSIBLE FOR THE

CELLULAR AND MOLECULAR

MANIFESTATIONS

OF NEURONAL AGING

DEVELOPMENT PIPELINE

We are developing multi-therapeutics that focus on the central nervous system. Our research programs aim to explore the potential of our scientific discovery in addressing a broad range of inflammatory-based brain health concerns.

CLINICAL STUDIES

Our clinical research programs focus on evaluating the scientific efficacy of our neuroprotective compounds and plays a vital role in helping advance the field of brain health.

Senescence Life Sciences Clinical Studies Summary Table

PILOT STUDY ON COGNITIVE BENEFITS OF EDGE™

Status: In Progress

Enrollment: Closed

To learn more about our pilot study on REVIVE™ contact: researchteam@senescence.life.

 

Pilot Study On The Cognitive Benefits Of EDGE Brain Supplement

PILOT STUDY ON COGNITIVE BENEFITS OF REVIVE™

Status: In progress

Enrollment: Closed

To learn more about our pilot study on REVIVE™ contact: researchteam@senescence.life.

Pilot Study On The Cognitive Benefits Of REVIVE Brain Supplement

Clinical trial on mild cognitive impairment

Status: planning

We anticipate trial initiation for our mild cognitive impairment trials in Q1 2019.

To learn more about our mild cognitive impairment trials contact: researchteam@senescence.life.

Senescence Life Sciences Clinical Trial On Mild Cognitive Impairment

Clinical trial on early stage Alzheimer's Disease

Status: planning

We anticipate trial initiation for our early stage Alzheimer’s disease trials in Q1 2019.

To learn more about our early stage Alzheimer's disease trials contact: researchteam@senescence.life.

Senescence Life Sciences Clinical Trial On Early Stage Alzheimer's Disease

Pilot study on Post-traumatic stress disorder

Status: Enrolling

We are currently enrolling individuals diagnosed with post-traumatic stress disorder (PTSD) to test the therapeutic potential of NeuroSHIELD™ in alleviating symptoms of PTSD.

To learn more about our PTSD study contact: researchteam@senescence.life.

Senescence Life Sciences Pilot Study On PTSD

pilot study on decision fatigue

Status: R&D

We anticipate trial initiation for our decision fatigue study in Q3 2019.

To learn more about our decision fatigue study contact: researchteam@senescence.life.

Senescence Life Sciences Pilot Study On Decision Fatigue.